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Long-term exposure to new peritoneal dialysis solutions: Ef-
fects on the peritoneal membrane.
Background. Chronic exposure to peritoneal dialysis fluid
(PDF) affects the peritoneum, but precise causative factors are
incompletely understood. We examined the effects of standard
and new PDF on peritoneal function and structure.
Methods. Female Wistar rats received twice daily intraperi-
toneal infusions of a standard lactate-buffered 3.86% glucose
PDF at pH 5.5 (Dianeal) (N = 12), a low glucose degra-
dation product (GDP) containing bicarbonate/lactate-buffered
3.86% glucose PDF at pH 7.4 (Physioneal) (N = 12), a lactate-
buffered amino acid–based PDF at pH 6.7 (Nutrineal) (N =
12) or Earle’s Balanced Salt Solution at pH 7.4 (EBSS) (N =
12) during 12 weeks.
Results. Net ultrafiltration was lower after treatment with
standard PDF, but not with low-GDP bicarbonate/lactate-
buffered and amino acid–based PDF, compared to EBSS. Peri-
tonea exposed to standard PDF were characterized by an
increased expression of vascular endothelial growth factor
(VEGF), microvascular proliferation as well as submesothe-
lial fibrosis, which were not observed in other groups. Stain-
ing for methylglyoxal adducts was prominent in the standard
PDF-exposed group, mild in the low GDP bicarbonate/lactate-
buffered group and absent in the other groups. Standard PDF
induced accumulation of advanced glycation end products
(AGEs) and up-regulation of the receptor for AGE (RAGE).
AGEs accumulation was absent and RAGE expression was only
modestly increased in low-GDP bicarbonate/lactate-buffered
and amino acid–based PDF.
Conclusion. Long-term in vivo exposure to standard PDF ad-
versely affects peritoneal function and structure. A low-GDP
bicarbonate/lactate-buffered and amino acid–based PDF bet-
ter preserved peritoneal integrity and may thus improve the
longevity of the peritoneal membrane. GDPs and associated
accelerated AGE formation are the main causative factors in
PDF-induced peritoneal damage.
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The performance of the peritoneum as a dialyzing
membrane can be compromised by the development of
various structural and functional alterations occurring in
the course of long-term peritoneal dialysis treatment [1].
Morphologically, a chronically exposed peritoneal mem-
brane is characterized by interstitial fibrosis, reduplica-
tion of basement membrane of the mesothelium and the
blood vessels, hyalinization of the blood vessel media,
and neoangiogenesis. Functionally, increased transport
of small solutes and a loss of ultrafiltration capacity may
develop, for which an increased effective vascular surface
area is held responsible.
Evidence is mounting that standard peritoneal dialysis
fluids (PDF) play a pathogenic role in the development of
peritoneal changes. The relative contribution of the dif-
ferent PDF components in mediating peritoneal changes
is, however, incompletely understood. As the described
structural alterations resemble those that occur in dia-
betes, it was hypothesized that high glucose is an impor-
tant contributing factor. In vitro exposure of endothelial
and mesothelial cells to high glucose stimulates the ex-
pression of vascular endothelial growth factor (VEGF)
[2, 3] and transforming growth factor b (TGF-b) [4, 5].
Chronic in vivo exposure of the peritoneal membrane
to high glucose concentrations resulted in microvascu-
lar proliferation and submesothelial fibrosis, mediated by
VEGF and TGF-b , respectively [6, 7].
Glucose carmelization during heat-sterilization and
storage of PDF results in the formation of glucose degra-
dation products (GDPs), such as formaldehyde, acetalde-
hyde, glyoxal, methylglyoxal (MGO), 3-deoxyglucosone,
and 3,4-dideoxyglucosone-3-ene [8]. MGO stimulates
VEGF synthesis by peritoneal mesothelial and endothe-
lial cells, which implies that GDPs may contribute to
the vascular proliferation in the peritoneal membrane
[9]. Glucose and reactive carbonyl compounds, such as
MGO, glyoxal, and 3-deoxyglucosone have the potential
to bind nonenzymatically to free amino groups on pro-
teins or lipids and form irreversible advanced glycation
endproducts (AGEs). AGEs promote in vitro VEGF ex-
pression in several cell types in vitro [10, 11]. Vascular
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Table 1. Composition of the solutions
Earle’s Balanced
Salt Solution
Dianeal Physioneal Nutrineal (EBSS)
pH 5.5 7.4 6.7 7.4
Osmolality mOsmol/L 483 483 367 290
Osmotic agent mmol/L Glucose (214) Glucose (214) Amino acids (87) Glucose (5.6)
Buffer Lactate Lactate/bicarbonate Lactate Bicarbonate
Glucose degradation product (GDP) content lmol/L: High Low Low Low
3-deoxyglucosone 525 ± 51 253 ± 30 <0.1 NA
Methylglyoxal 6.9 ± 0.5 1.1 ± 0.2 0.3 ± 0.2 NA
Glyoxal 9.4 ± 2.2 6.0 ± 1.6 0.8 ± 0.1 NA
Glucose degradation product (GDP) levels (a mean of three different batches) were taken from Schalkwijk, ter Wee, and Teerlink [37]. <, below limit of detection;
NA, data not available.
and interstitial AGE content correlated with the extent
of vascular sclerosis and interstitial fibrosis in the peri-
toneal membrane of long-term peritoneal dialysis pa-
tients [12]. Functionally, AGE formation was associated
with a decrease in ultrafiltration volume [12] and an in-
creased transport of various soluta [13]. The best char-
acterized of the AGE receptors has been termed the
receptor for AGE (RAGE), although other AGE-
binding structures have been described [14]. Chronic ex-
posure to high glucose concentrations greatly increased
peritoneal expression of RAGE, most distinctly in the
mesothelium, submesothelial fibrotic tissue, and blood
vessel walls. The development of high glucose-induced
interstitial fibrosis in the peritoneal membrane was pre-
vented by an anti-RAGE antibody [7].
Finally, the lactate buffer has been implicated in al-
tering peritoneal structure. In vivo exposure of mice to
40 mmol/L lactate induced mesothelial damage, although
not as pronounced as contact with standard PDF [15].
Cultured peritoneal fibroblasts produced more collagen
when exposed to increasing concentrations of lactate
(10 mmol/L to 40 mmol/L) [16]. Replacement of lactate
by pyruvate in PDF prevented the development of both
neoangiogenesis and fibrosis during chronic in vivo ex-
posure in rats [abstract; Van Westrheenen R, Perit Dial
Int 22:154, 2002].
Low-GDP or nonglucose-based PDF and PDF with al-
ternative buffers are currently available. The aim of the
present study was to investigate the effects of new PDF on
the peritoneal membrane. More, in particular, the relative
contribution of glucose, GDPs, and lactate in the develop-
ment of functional and structural alterations in the peri-
toneum were examined. To this end, the effects of chronic
exposure to a standard acidic lactate-buffered PDF, a
double-chambered, physiologic pH bicarbonate/lactate-




The studies were performed in 48 female Wistar rats
(Iffacredo, Brussels, Belgium) with a mean body weight
of 213±1 g, receiving care in accordance with the national
guidelines for care and use of laboratory animals. A sub-
cutaneous port (PMINA-CBAS-C30 Soloport) (Instech
Solomon, Plymouth Meeting, MA, USA) was implanted
in the neck under halothane (Fluothane) (Zeneca,
Destelbergen, Belgium) anesthesia in sterile conditions.
The attached polyurethane, heparin-coated catheter (In-
stech Solomon) was tunneled over the left flank to the
peritoneal cavity [17]. After surgery, the animals received
an intramuscular injection of buprenorphine (0.1 mL/kg)
(Temgesic) (Schering Plough NV/SA, Brussels, Belgium).
The first week after implantation, catheters were flushed
once daily with 1 mL of Earle’s Balanced Salt So-
lution (EBSS) (ICN Biomedicals Inc., Aurora, OH,
USA). Thereafter, 10 mL of PDF was administered
twice daily during 12 weeks. Oxacilline (2.5 mg/day)
(Penstapho) (Bristol-Myers Squibb, Brussels, Belgium)
and gentamycine (0.04 mg/day) (Geomycine) (Shering-
Plough NV/SA) were added to all solutions [18].
Laboratory technicians wore masks and gloves during
manipulations. The area of the port was disinfected with
ethanol 97% 20 seconds before puncture.
Study protocol
Animals received twice daily intraperitoneal infusions
of 10 mL of a standard lactate-buffered 3.86% glu-
cose PDF at pH 5.5 (Dianeal) (Baxter, SA, Lessines,
Belgium) (N = 12), a low GDP bicarbonate/lactate-
buffered 3.86% glucose PDF at pH 7.4 (Physioneal)
(Baxter) (N = 12), a lactate-buffered amino acid–based
PDF at pH 6.7 (Nutrineal) (Baxter) (N = 12) or EBSS
at pH 7.4 (N = 12) (Table 1). The weight of the rats
was recorded weekly. Catheter patency and the integrity
of the skin of the abdomen and around the port were
evaluated twice daily. In case of catheter obstruction, an
attempt was made to infuse fluids under halothane anes-
thesia. In case of persistent catheter obstruction, skin
lesions, or severe weight loss, dialysate and catheter tip
cultures as well as dialysate white blood cell counts were
obtained and the animal was sacrificed. At 4-week in-
tervals, dialysate cultures and white blood cell counts
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were performed on 2 mL of fluid obtained through a ster-
ile abdominal puncture with a silicon catheter (Venflon)
(Becton Dickinson, Erembodegem-Aalst, Belgium) un-
der halothane anesthesia 4 hours after the last dialysate
injection. White blood cell counts were performed in a
Bu¨rker chamber. Infection was arbitrarily defined as a
positive dialysate culture with a dialysate white blood
cell count higher than 1000/mm3 [17].
Study of peritoneal function
After 12 weeks of dialysate exposure, rats were anaes-
thetized with thiobutabarbital (Inactin, RBI, Natick, MA,
USA) (100 mg/kg subcutaneously). The trachea was
intubated and a jugular vein was cannulated for contin-
uous infusion of isotonic saline. After 30 minutes, a sili-
cone catheter was inserted in the abdomen and 15 mL of
3.86% Dianeal was infused. After 120 minutes, dialysate
was recovered through the silicone catheter and samples
were obtained for culture and white blood cell counts.
The abdomen was opened by midline incision to collect
the rest of the dialysate for determination of net ultrafil-
tration and to sample tissue. The tunneled polyurethane
catheter was removed in a sterile way and the tip was
cultured.
Study of peritoneal morphology
One sample of visceral and parietal peritoneum was
obtained in each experimental animal in a standardized
manner. Parietal peritoneum was obtained at the right
hand side of the linea alba and visceral peritoneum was
taken from the most distal loop of the small bowel. The
samples were fixed in 4% neutral buffered formalin and
embedded in paraffin. Five micrometer sections were cut
for histology and immunohistochemistry.
The degree of fibrosis was evaluated using a Picro
Sirius Red staining F3B (Klinipath, Geel, Belgium). Sec-
tions were deparaffinized, rehydrated, and stained briefly
with Giemsa. Subsequently, sections were washed and
stained with the Sirius Red solution, resulting in a brick
red staining of all fibrillary collagen.
Immunostaining for endothelial nitric oxide synthase
(eNOS), VEGF, MGO adducts, AGE, and RAGE were
performed. Sections were deparaffinized, rehydrated, in-
cubated in 3% H2O2 in phosphate-buffered saline (PBS)
for 15 minutes to block endogenous peroxidase and
washed in 10% normal horse serum (Sigma, St. Louis,
MO, USA) in PBS for 20 minutes to block nonspe-
cific binding. Subsequently, they were incubated with the
primary antibody, mouse antihuman eNOS (Transduc-
tion Laboratories, Lexington, KY, USA), mouse anti-
human VEGF (Santa Cruz Biotechnology, Santa Cruz,
CA, USA), mouse antihuman MGO adduct, mouse an-
tihuman AGE (6D12) (Cosmo Bio Ltd., Tokyo, Japan)
and goat antihuman RAGE (Research Diagnostics,
Flanders, NJ, USA), respectively. Thereafter, a biotiny-
lated IgG (Vector Laboratories, Burlingame, CA, USA)
and streptavidine-peroxidase were applied for 45 minutes
each. 3,3′ diaminobenzidine (DAB) was used as the chro-
mogenic substrate to visualize immunolabeling, resulting
in a brown precipitate.
The mouse monoclonal antibody specific for MGO
adducts was developed using MGO-modified keyhole
limpet hemocyanin (KLH), that was prepared by the re-
action of MGO (10 mmol/L) with KHL for 7 days at
37◦C, as antigen for the immunization of mice. Ten days
after the final booster, antisera were tested with MGO-
albumin and the mouse with the highest titer was used
for fusion. One out of 40 clones was further character-
ized. The monoclonal antibody is an IgG1 and has a
tenfold preference for 5-hydro-5-methyl-4-imidazolone
and/or tetrahydropyrimidine as compared to agrypyrim-
idine, which are three of the characterized epitopes that
are formed after the reaction of MGO with arginine [19].
The monoclonal anti-AGE antibody 6D12 recognizes
carboxymethyllysine (CML)-like structures, as well as
carboxyethyllysine (CEL) and several unidentified AGE
epitopes [20].
Morphometric analysis
Morphometric measurements of the Picro Sirius Red
staining and the eNOS, VEGF, MGO adduct, AGE, and
RAGE immunostaining were made by a blinded operator
with a Zeiss Axiophot microscope (Zeiss, Oberkochen,
Germany) at magnification ×200. For each sample of
peritoneum, two sections were analyzed quantitatively
with a computerized image analysis system (Zeiss). A
camera sampled the image of the stained sections and
generated an electronic signal proportional to the inten-
sity of illumination, which was then digitized into pic-
ture elements or pixels. The digital representation of the
tissue was analyzed with KS400 Software (Zeiss). Each
pixel in a color image was divided into three color com-
ponents (hue, saturation, and intensity). The threshold
for each color component of the staining was defined and
kept constant throughout the analysis. In a predefined
area, the Picro Sirius Red, VEGF, eNOS, MGO adduct,
AGE, and RAGE staining was measured and expressed
as a percentage. In addition, eNOS-labeled blood vessels
were counted as number/field. Mesothelial damage was
evaluated on the Picro Sirius Red staining by measuring
the length of damaged mesothelium and expressing it as
percentage of total mesothelial length.
Statistical analyses
The results are expressed as mean ± SEM. Statisti-
cal analysis was performed using analysis of variance
(ANOVA) and, where appropriate, the Tukey test was


















Fig. 1. Net ultrafiltration after a 120-minute dwell of 15 mL of 3.86%
glucose dialysate in experimental animals exposed to the standard
peritoneal dialysis fluid (PDF) (N = 10) (), low-glucose degra-
dation product (GDP) bicarbonate/lactate-buffered PDF (N = 10)
( ), amino acid–based PDF (N = 9) (), and Earle’s Balanced Salt
Solution (EBSS) (N = 10) (). ∗P < 0.05 vs. EBSS, low-GDP
bicarbonate/lactate-buffered PDF, and amino acid–based PDF.
used as multiple comparison t test. The significance level
was set at P ≤ 0.05.
RESULTS
Technique survival and infection rate of
laboratory animals
Body weight was similar in the different experimental
groups at all time points (data not shown). Technique
survival was 83% in the standard PDF, the low-GDP
bicarbonate/lactate-buffered PDF and EBSS group and
75% in the amino acid–based PDF group. Drop-out was
caused by open abdominal wound with catheter damage
(N = 2) and leakage around the catheter port (N = 7). No
episodes of infection, defined as a positive dialysate cul-
ture and a dialysate white blood cell count >1000/mm3,
were diagnosed (data not shown).
Ultrafiltration
Net ultrafiltration was significantly lower in the ani-
mals that were exposed to the standard PDF, as compared
to those treated with low-GDP bicarbonate/lactate-
buffered PDF, amino acid–based PDF and EBSS (Fig. 1).
Net ultrafiltration was not different among the latter
three groups.
Peritoneal morphology
Standard PDF exposure caused an upregulation of
eNOS expression and increased vascular density, as
compared to all other groups (Table 2) (Fig. 2). No
differences in eNOS expression and vascular density
were observed between animals treated with low-GDP
bicarbonate/lactate-buffered PDF, amino acid–based
PDF and EBSS. Similarly, VEGF expression was in-
creased in standard PDF-exposed peritonea, most
distinctly in the mesothelial cell layer and in the blood
vessel wall (Table 2) (Fig. 3). VEGF immunostaining was
not different between the other groups (Table 2) (Fig. 3).
An inverse correlation was observed between net ultra-
filtration and the number of blood vessels/area (Pearson
r = −0.3696, P < 0.05). In addition, vascular density
and VEGF expression correlated positively (Pearson
r = 0.6745, P < 0.0001). Submesothelial fibrosis was more
pronounced in animals exposed to standard PDF, than in
the other experimental groups (Table 2) (Fig. 4). No cor-
relation was observed between net ultrafiltration and the
degree of fibrosis in the peritoneal tissue (Pearson r =
−0.1716, P = 0.31).
Long-term exposure to standard PDF was associated
with prominent staining for MGO adducts, especially
in the vascular wall and mesothelium. A more mod-
est staining for MGO adducts was visible in the low-
GDP bicarbonate/lactate-buffered PDF group. No MGO
adducts accumulation was present in the peritoneum of
rats treated with amino acid–based PDF and EBSS (Ta-
ble 2) (Fig. 5). The staining for MGO adducts correlated
positively with VEGF expression and vascular density
(Pearson r = 0.5043, P < 0.001 and Pearson r = 0.4089,
P < 0.01, respectively).
AGE strongly accumulated in peritoneal tissue ex-
posed to standard PDF, which was most obvious in the
mesothelial layer and the areas of neoangiogenesis. Vir-
tually no AGE staining was observed in the other groups
(Table 2) (Fig. 6). RAGE expression was higher in all
PDF-exposed peritonea, but the most prominent expres-
sion was observed in animals treated with standard PDF
and was localized in the mesothelial layer, submesothelial
fibrotic tissue, and blood vessel walls (Table 2) (Fig. 7).
MGO adducts accumulation significantly correlated with
the staining for AGE and RAGE (Pearson r = 0.4471,
P < 0.005 and Pearson r = 0.3751, P < 0.05). In addi-
tion, fibrosis correlated positively with the staining for
MGO adducts, AGE and RAGE (Pearson r = 0.4809,
P < 0.005, Pearson r = 0.4843, P < 0.005 and Pearson r =
0.4455, P < 0.01, respectively). The staining for AGE and
RAGE also correlated with VEGF expression (Pearson
r = 0.4928, P < 0.005 and Pearson r = 0.4015, P < 0.05,
respectively), but not with vascular density.
Standard PDF caused significant mesothelial damage
as compared to all other groups (Table 2).
DISCUSSION
Chronic exposure of the rat peritoneal membrane to a
high-glucose standard PDF results in mesothelial dam-
age, development of submesothelial and interstitial fibro-
sis and pronounced neoangiogenesis, the latter evidenced
by an increased eNOS expression and vascular density.
Functionally, the membrane is characterized by a promi-
nent loss of ultrafiltration capacity. These functional
and structural characteristics of the peritoneal membrane
Mortier et al: Effects of new dialysis solutions on peritoneal function and morphology 1261
Table 2. Histologic and immunohistochemical analysis of the peritoneum
Earle’s Balanced
Dianeal Physioneal Nutrineal Salt Solution (EBSS)
(N = 10) (N = 10) (N = 9) (N = 10)
Blood vessels number/mm2 174 ± 17a 97 ± 9 102 ± 2 95 ± 5
eNOS staining % 0.28 ± 0.09b 0.17 ± 0.09 0.17 ± 0.3 0.18 ± 0.2
VEGF staining % 1.41 ± 0.22b 0.83 ± 0.15 0.53 ± 0.15 0.49 ± 0.08
Picro Sirius Red staining % 4.11 ± 2.39a 1.47 ± 1.09 1.44 ± 0.79 0.87 ± 0.52
Methylglyoxal staining % 3.75 ± 0.75b 2.28 ± 0.72c 1.40 ± 0.97 1.33 ± 0.32
AGE staining % 1.70 ± 0.23b 0.92 ± 0.04 0.96 ± 0.13 1.02 ± 0.05
RAGE staining % 2.48 ± 0.31b 1.58 ± 0.25d 1.47 ± 0.27d 0.46 ± 0.11
Mesothelial damage % 8.04 ± 2.04b 2.24 ± 1.29 0.20 ± 0.13 1.28 ± 0.82
Abbreviations are: eNOS, endothelial nitric oxide synthase; VEGF, vascular endothelial growth factor; AGE, advanced glycation end products; RAGE, receptors of
AGE.
aP < 0.005 vs. EBSS, low-glucose degradation product (GDP) bicarbonate/lactate-buffered peritoneal dialysis fluid (PDF), and amino acid–based PDF.
bP < 0.05 vs. EBSS, low-GDP bicarbonate/lactate-buffered PDF, and amino acid–based PDF.
cP < 0.01 vs. EBSS and amino acid–based PDF.
dP < 0.005 vs. EBSS.
Fig. 2. Immunostaining for endothelial nitric oxide synthase (eNOS)
of the visceral peritoneum. (A) Prominent eNOS staining was present
after 12 weeks’ exposure to standard peritoneal dialysis fluid (PDF)
(×200). (B) Detail of the eNOS staining in the vascular endothelium
of a standard PDF-treated rat (×630). Animals exposed to low-glucose
degradation product (GDP) bicarbonate/lactate-buffered PDF (C), and
amino acid–based PDF (D) showed an eNOS staining comparable to
the Earle’s Balanced Salt Solution (EBSS)-exposed group (E) (×200).
No specific staining is observed when sections are incubated without
primary antibody (F) (×200).
are similar of those found in patients on long-term peri-
toneal dialysis [21, 22], thus underlining the relevance
of our experimental model. The salient observation of
the present study is that the ultrafiltration failure as
Fig. 3. Immunostaining for vascular endothelial growth factor (VEGF)
staining of the visceral peritoneum. (A) VEGF staining was prominent
in the mesothelial cells and vascular wall of standard peritoneal dialysis
fluid (PDF)-exposed rats (×200). (B) Detail of mesothelium and blood
vessel of a rat exposed to standard PDF (×630). No pronounced stain-
ing was observed in rats exposed to low-glucose degradation product
(GDP) bicarbonate/lactate-buffered PDF (C), amino acid–based PDF
(D), and Earle’s Balanced Salt Solution (EBSS) (E) (×200). No spe-
cific staining is observed when sections are incubated without primary
antibody (F) (×200).
well as the diverse structural alterations were absent or
much less pronounced with an amino acid–based PDF
or a bicarbonate/lactate-buffered PDF with a low GDP
content.
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Fig. 4. Picro Sirius Red staining of the visceral peritoneum. (A) Ani-
mals exposed to standard peritoneal dialysis fluid (PDF) for 12 weeks
showed a prominent deposition of fibrous tissue (×200). Detail of the
submesothelial fibrotic tissue in a standard PDF-treated animal (×630)
(B). Almost no fibrosis was present in the animals exposed to low-
glucose degradation product (GDP) bicarbonate/lactate-buffered PDF
(C), amino acid–based PDF (D), and Earle’s Balanced Salt Solution
(EBSS) (E) (×200).
Both the standard PDF and the bicarbonate/lactate-
buffered PDF with low GDP content use glucose as the
osmotic agent and both the standard PDF and the amino
acid–based PDF are characterized by a nonphysiologic
pH and use lactate as the buffer. Only the standard PDF,
however, contains a high level of GDPs. The double
chamber design of the bicarbonate/lactate-buffered PDF
allows glucose to be sterilized at a very low pH, substan-
tially reducing GDP formation. As the amino acid–based
PDF is nonglucose based, it contains no GDPs at all.
Taken together, the present results point to GDPs as the
principal causative factor for peritoneal damage.
The causality of GDPs in disturbing viability and
normal function in cultured mesothelial cells is a
well-established phenomenon. A better preservation
of the integrity of the mesothelial cell layer with the
bicarbonate/lactate-buffered PDF than with standard
PDF has previously been observed [23, 24], but the re-
sults could not be ascribed with certainty to differences
in GDP content, as high lactate concentrations are also
known to affect mesothelial cell viability in vitro [25].
The amino acid–based PDF did not convey prominent
mesothelial damage, although it also contains high lac-
Fig. 5. Immunostaining for methylglyoxal (MGO) adducts of the vis-
ceral peritoneum. (A) MGO adducts strongly accumulated in peri-
toneal tissue exposed to standard peritoneal dialysis fluid (PDF) (×200)
and to a lesser extent in low-glucose degradation product (GDP)
bicarbonate/lactate-buffered PDF (B) (×200). No MGO adduct accu-
mulation was observed in animals exposed to amino acid–based PDF
(C) (×200) or Earle’s Balanced Salt Solution (EBSS) (D) (×200). No
specific staining is observed when sections are incubated without pri-
mary antibody (E) (×200).
tate concentrations. The present findings thus strongly
incriminate GDPs as responsible for PDF-induced in vivo
mesothelial cell loss.
The involvement of GDPs in peritoneal neoangiogene-
sis has been suggested repeatedly, though direct evidence
has not been provided yet. So far, only one study demon-
strated up-regulation of VEGF expression by MGO in
mesothelial and endothelial cells in vitro, as well as in the
peritoneal membrane in vivo [9]. VEGF is a known pro-
motor of peritoneal neoangiogenesis [6]. Several lines of
recent evidence have supported a strong causative link
between peritoneal neoangiogenesis and loss of ultrafil-
tration capacity [7, 26]. In the present study, exposure
to standard PDF resulted in an increased staining for
VEGF, an increased vascular density, and a lower ultra-
filtration rate, with correlations between these four pa-
rameters. While these findings are descriptive and do not
demonstrate causality, they support the previously for-
mulated hypothesis that VEGF mediates neoangiogene-
sis and subsequent ultrafiltration failure [6]. Although the
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Fig. 6. Immunostaining for advanced glycation end products (AGE) of
the visceral peritoneum. (A) Standard peritoneal dialysis fluid (PDF)
exposure resulted in AGE accumulation in peritoneal tissue (×200).
Detail of AGE localization in the standard PDF-exposed blood vessels
(B) and mesothelium (C) (×630). In contrast, almost no AGE accumu-
lation was present in tissue exposed to low-glucose degradation product
(GDP) bicarbonate/lactate-buffered PDF (D), amino acid-based PDF
(E), and Earle’s Balanced Salt Solution (EBSS) (F) (×200). No spe-
cific staining is observed when sections are incubated without primary
antibody (G) (×200).
potential of high glucose concentrations to up-regulate
VEGF expression in several cell types is well-established
[2, 3, 27] and to cause angiogenesis in vivo [28], exposure
to high glucose bicarbonate/lactate-buffered PDF was
counter-intuitively not associated with increased VEGF
expression or vascular density. In contrast with our find-
ings, chronic exposure to a bicarbonate/lactate-buffered
PDF was associated with a higher vascular density com-
pared to the control group, though not to the same
extent as a standard PDF. It should be noted that the
control group was left untreated [23]. The present re-
sults, however, suggest that GDPs may be the principal
Fig. 7. Immunostaining for receptor for advanced glycation end prod-
ucts (RAGE) of the visceral peritoneum. (A) RAGE staining was ele-
vated in the standard peritoneal dialysis fluid (PDF)-exposed animals
compared to the other PDF-treated groups (×200). Detail of RAGE-
stained vascular tissue (B) and mesothelium (C) in a standard PDF-
treated rat (×630). Low-grade staining was detected in animals treated
with low-glucose degradation product (GDP) bicarbonate/lactate-
buffered PDF (D) and amino acid–based PDF (E) which was signif-
icantly higher than those exposed to Earle’s Balanced Salt Solution
(EBSS) (F) (×200). No specific staining is observed when sections are
incubated without primary antibody (G) (×200).
mediators of peritoneal neoangiogenesis. Comparison of
heat-sterilized versus filter-sterilized PDF could further
strengthen this hypothesis.
GDPs are known to promote AGE generation in vitro
[29]. MGO adducts strongly accumulated in the peritonea
exposed to standard PDF. Only mild staining for MGO
adducts was present in the low-GDP bicarbonate/lactate-
buffered PDF group, corresponding with low MGO levels
in this PDF. No staining for MGO adducts was observed
in the amino acid–based PDF and EBSS group. AGE
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accumulation was indeed prominent in the peritonea ex-
posed to standard PDF, mainly in the mesothelial layer
where contact with the PDF is most intense, but also in ar-
eas of neoangiogenesis and correlated with MGO adduct
accumulation. The results are commensurate with clin-
ical studies demonstrating progressive AGE accumula-
tion in the peritoneal membrane of long-term peritoneal
dialysis patients [30, 31]. Virtually no AGE formation
was seen in the low-GDP PDF groups, suggesting that
high glucose exposure by itself is not sufficient to produce
AGEs. The pathogenicity of AGEs hinges on their abil-
ity to form cross-links with matrix proteins, resulting in
an increased tissue thickness and rigidity. Moreover, they
trigger a variety of signal transduction pathways through
interaction with specific cellular receptors. RAGE, de-
fined as the receptor for AGE, is best characterized of
these AGE-binding structures [14]. Human peritoneal
mesothelial cells are known to express functional RAGE
in vitro [32]. In a normal peritoneal membrane, RAGE
expression is low-grade [7], as it is in other tissues in the
absence of disease processes [14]. Conditions character-
ized by cellular activation, including diabetes, uremia, and
inflammation, are associated with strong up-regulation of
RAGE expression. In addition, AGE ligands themselves
are potent inducers of RAGE gene transcription [33].
RAGE expression was profoundly enhanced in the peri-
tonea exposed to standard PDF, but a less pronounced
expression was also found in the low-GDP bicarbonate/
lactate-buffered and the amino acids–based PDF groups.
The etiology nor the consequences of the latter observa-
tion are presently clear.
Both AGE accumulation and RAGE expression cor-
related strongly with the degree of fibrosis in the peri-
toneal membrane. The fibrotic properties of AGEs are
well-known [34]. We have previously demonstrated that
binding of AGE to RAGE results in peritoneal fibrosis
with TGF-b as downstream mediator [7].
AGEs have been implicated in PDF-induced neoan-
giogenesis, by virtue of their ability to up-regulate VEGF
expression in diverse cell types [11, 35]. The correla-
tion between AGE accumulation and VEGF expression
makes it tempting to speculate that they function as
upstream mediators of VEGF-induced neoangiogenesis,
though no causality was demonstrated. Inhibition of
AGE-RAGE interaction did not prevent peritoneal an-
giogenesis [7]. AGEs may, however, up-regulate VEGF
expression through binding with other receptors or
nonreceptor-mediated mechanisms.
Although GDPs and the associated accelerated AGE
formation appear as the principal causative factors of
peritoneal dialysis–related membrane alterations, a role
for combined low pH and high lactate concentrations is
not entirely ruled out. Equilibration of PDF during the
dialysis procedure results in a neutralization of the pH
within 30 minutes and a reduction of the lactate concen-
tration to 12.5 mmol/L within the first hour of dialysis
[36], thus weakening their potential to provoke perse-
vering membrane damage. Chronic exposure to an acidic
lactate buffer without glucose, however, was associated
with peritoneal angiogenesis, but the control group was
left untreated [28]. It thus remains unclear to what extent
these observations were related to the combined effect of
high lactate concentrations and low pH or to the repeated
fluid instillation, mechanical trauma, and potential intro-
duction of infection.
CONCLUSION
Long-term exposure of the peritoneal membrane to
low-GDP or non-GDP PDF was not associated with
the development of structural and functional alterations
that were prominently present after exposure to stan-
dard PDF. As GDPs and associated accelerated AGE
formation appear to be the main pathogenetic factors
in the progressive membrane deterioration, technologic
and pharmacologic strategies reducing GDP and/or AGE
formation have the potential to better preserve long-term
peritoneal membrane integrity.
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